Please assess the completion status of the following clinical trial:

Trial Title: Tigecycline for Treatment of Rapidly Growing Mycobacteria

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE2
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Positive cultures for rapidly growing mycobacteria~* Patients who have drug resistant isolates or are intolerant of macrolides or have serious infections unresponsive to currently available drugs~* Adults and children 10 years of age and older~* Pretreatment isolate of M. avium complex available for MIC determination~* Available for followup appointments~Exclusion Criteria:~* History of tetracycline allergy~* If a menstruating female, not pregnant and on adequate birth control

- Gender: ALL
- Minimum Age: 10 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Tigecycline (Type: EXPERIMENTAL): tigecycline titrated dose according to patient age and clinical status

Based on this trial design, predict the completion outcome and termination type (if applicable).